Loading
Latest filing published 06 Apr 2011 for GENZYME CORP.
No signal scores available.
Steven Burakoff discloses dealings in Genzyme Corp to SEC (Form 4). Altogether 2 filings, all relating to 4 April 2011.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 6 April 2011, reports an option exercise in Genzyme Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration